ArticleCancers2026

Efficacy and Safety of Dalpiciclib in HR-Positive Advanced Breast Cancer: A Two-Center Retrospective Study.

Jingjing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.